Lancet

• Latest
• Best
• Search…

• Lancet · Sep 2020

  Comment Letter

  Health-care crisis in Kashmir.

  no abstract available

  expand abstract… mark as read…

• Lancet · Sep 2020

  Comment Letter

  Kashmir and medical education.

  no abstract available

  expand abstract… or not…

• Lancet · Sep 2020

  Noel Richard Rose.

  no abstract available

  expand abstract… or not…

• Lancet · Sep 2020

  Multicenter Study

  Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.

  We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein (rAd26-S and rAd5-S). We aimed to assess the safety and immunogenicity of two formulations (frozen and lyophilised) of this vaccine. ⋯ Ministry of Health of the Russian Federation.

  read more… or not…

• Lancet · Sep 2020

  Comment

  COVID-19 vaccines: early success and remaining challenges.

  no abstract available

  read more… or not…